Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study
…, Z Ma, S Lu, Y Xiao, Y Gu, J Zhang, H Yao, K Xu… - bmj, 2020 - bmj.com
Objective To evaluate viral loads at different stages of disease progression in patients infected
with the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the …
with the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the …
[HTML][HTML] A deep learning system to screen novel coronavirus disease 2019 pneumonia
X Xu, X Jiang, C Ma, P Du, X Li, S Lv, L Yu, Q Ni… - Engineering, 2020 - Elsevier
The real-time reverse transcription-polymerase chain reaction (RT-PCR) detection of viral
RNA from sputum or nasopharyngeal swab had a relatively low positive rate in the early stage …
RNA from sputum or nasopharyngeal swab had a relatively low positive rate in the early stage …
Polymer-and lipid-based nanoparticle therapeutics for the treatment of liver diseases
Liver diseases, particularly hepatitis B virus infections, liver cirrhosis and hepatocellular
carcinoma continue to pose a significant health challenge worldwide due to the dire lack of …
carcinoma continue to pose a significant health challenge worldwide due to the dire lack of …
Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019 (COVID-19)
K Xu, Y Chen, J Yuan, P Yi, C Ding… - Clinical infectious …, 2020 - academic.oup.com
Background An outbreak of coronavirus disease 2019 (COVID-19) is becoming a public
health emergency. Data are limited on the duration and host factors related to viral shedding. …
health emergency. Data are limited on the duration and host factors related to viral shedding. …
Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent
L Liu, K Xu, H Wang, PK Jeremy Tan, W Fan… - Nature …, 2009 - nature.com
Antimicrobial cationic peptides are of interest because they can combat multi-drug-resistant
microbes. Most peptides form α-helices or β-sheet-like structures that can insert into and …
microbes. Most peptides form α-helices or β-sheet-like structures that can insert into and …
Management of COVID-19: the Zhejiang experience
K Xu, H Cai, Y Shen, Q Ni, Y Chen, S Hu… - Zhejiang da xue xue …, 2020 - europepmc.org
The current epidemic situation of coronavirus disease 2019 (COVID-19) still remained
severe. As the National Clinical Research Center for Infectious Diseases, the First Affiliated …
severe. As the National Clinical Research Center for Infectious Diseases, the First Affiliated …
Biodegradable nanostructures with selective lysis of microbial membranes
Macromolecular antimicrobial agents such as cationic polymers and peptides have recently
been under an increased level of scrutiny because they can combat multi-drug-resistant …
been under an increased level of scrutiny because they can combat multi-drug-resistant …
[HTML][HTML] Lack of vertical transmission of severe acute respiratory syndrome coronavirus 2, China
Y Li, R Zhao, S Zheng, XU Chen, J Wang… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
A woman with coronavirus disease in her 35th week of pregnancy delivered an infant by
cesarean section in a negative-pressure operating room. The infant was negative for severe …
cesarean section in a negative-pressure operating room. The infant was negative for severe …
[HTML][HTML] Transmission of hepatitis B and C virus infection through body piercing: a systematic review and meta-analysis
S Yang, D Wang, Y Zhang, C Yu, J Ren, K Xu, M Deng… - Medicine, 2015 - journals.lww.com
Hepatitis B and hepatitis C are 2 types of potentially life-threatening liver diseases with high
infection rate. Body piercing represents a progressively popular sociocultural phenomenon …
infection rate. Body piercing represents a progressively popular sociocultural phenomenon …
Clinical outcomes and plasma concentrations of baloxavir marboxil and favipiravir in COVID-19 patients: an exploratory randomized, controlled trial
Y Lou, L Liu, H Yao, X Hu, J Su, K Xu, R Luo… - European Journal of …, 2021 - Elsevier
Background: Effective antiviral drugs for COVID-19 are still lacking. This study aims to
evaluate the clinical outcomes and plasma concentrations of baloxavir acid and favipiravir in …
evaluate the clinical outcomes and plasma concentrations of baloxavir acid and favipiravir in …